Pradžia › Nuovargis › Kalifornija
Nuovargis klinikiniai tyrimai Kalifornija
6 tyrimai dėl Nuovargis ieško dalyvių vietose Kalifornija.
Miestai Kalifornija
Oficialus tyrimo tekstas (anglų kalba)
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- UC San Diego Medical Center - Encinitas, Encinitas
- Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- UCI Health - Irvine, Irvine
- ir dar 14
Renkami dalyviai2/3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT06989437A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
- Stanford Center for Sleep Medicine, Redwood City
- Trial Site Solutions, San Ramon
- Santa Monica Clinical Trials, Santa Monica
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-14 · NCT07500090A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Alkermes Investigational Site, Los Angeles
Renkami dalyviai3 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-03 · NCT07455383A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
- West Coast Pulmonary & Sleep Disorders Center, Lancaster
- Santa Monica Clinical Trials, Los Angeles
- Stanford Center for Sleep Sciences and Medicine, Redwood City
- ir dar 2
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-27 · NCT07675135Biofield Therapy for the Support of Immunotherapy-related Symptoms Among Adult Cancer Patients - A Pilot Study
- UCI Health Susan Samueli Integrative Health Institute, Irvine
- UCI Health, Orange
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-10 · NCT07581080Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
- University of California Davis Health, Sacramento
Renkami dalyviai2 fazė
Amžius nuo 21 iki 85 · Visoms lytims · Atnaujinta 2026-05-06 · NCT04984226Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.